These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36399465)

  • 1. Impairment in quantitative microvascular function in non-ischemic cardiomyopathy as demonstrated using cardiovascular magnetic resonance.
    Slivnick JA; Zareba KM; Truong VT; Liu E; Barnes A; Mazur W; Binkley P
    PLoS One; 2022; 17(11):e0264454. PubMed ID: 36399465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
    Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
    BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of Myocardial Perfusion Reserve and Left Ventricular Ejection Fraction in Ischemic and Nonischemic Cardiomyopathy.
    Wang S; Patel H; Miller T; Ameyaw K; Miller P; Narang A; Kawaji K; Singh A; Landeras L; Liu XP; Mor-Avi V; Patel AR
    Am J Cardiol; 2022 Jul; 174():143-150. PubMed ID: 35487776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype, outcomes and natural history of early-stage non-ischaemic cardiomyopathy.
    Hammersley DJ; Jones RE; Owen R; Mach L; Lota AS; Khalique Z; De Marvao A; Androulakis E; Hatipoglu S; Gulati A; Reddy RK; Yoon WY; Talukder S; Shah R; Baruah R; Guha K; Pantazis A; Baksi AJ; Gregson J; Cleland JGF; Tayal U; Pennell DJ; Ware JS; Halliday BP; Prasad SK
    Eur J Heart Fail; 2023 Nov; 25(11):2050-2059. PubMed ID: 37728026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating Nonischemic Dilated Cardiomyopathy With Incidental Infarction From Ischemic Cardiomyopathy by Geometric Indices Derived From Cardiovascular Magnetic Resonance.
    Wang X; Costello BT; Papapostolou S; O'Brien J; Taylor A; Zhao S
    J Thorac Imaging; 2021 Jul; 36(4):248-253. PubMed ID: 32960835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy.
    Voskoboinik A; Wong MCG; Elliott JK; Costello BT; Prabhu S; Mariani JA; Kalman JM; Kistler PM; Taylor AJ; Morton JB
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1109-1115. PubMed ID: 29931686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
    Pöyhönen P; Kivistö S; Holmström M; Hänninen H
    BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Arnold JR; Kanagala P; Budgeon CA; Jerosch-Herold M; Gulsin GS; Singh A; Khan JN; Chan DCS; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2022 Jun; 15(6):1001-1011. PubMed ID: 35033490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging.
    Kim J; Kochav JD; Gurevich S; Afroz A; Petashnick M; Volo S; Diaz B; Okin PM; Horn E; Devereux RB; Weinsaft JW
    Int J Cardiovasc Imaging; 2014 Dec; 30(8):1559-67. PubMed ID: 25008088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Septal Late Gadolinium Enhancement and Arrhythmic Risk in Genetic and Acquired Non-Ischaemic Cardiomyopathies.
    Peretto G; Sala S; Lazzeroni D; Palmisano A; Gigli L; Esposito A; De Cobelli F; Camici PG; Mazzone P; Basso C; Della Bella P
    Heart Lung Circ; 2020 Sep; 29(9):1356-1365. PubMed ID: 32299760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative deformation analysis differentiates ischaemic and non-ischaemic cardiomyopathy: sub-group analysis of the VINDICATE trial.
    Foley JRJ; Swoboda PP; Fent GJ; Garg P; McDiarmid AK; Ripley DP; Erhayiem B; Musa TA; Dobson LE; Plein S; Witte KK; Greenwood JP
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):816-823. PubMed ID: 29029139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cine-cardiac magnetic resonance to distinguish between ischemic and non-ischemic cardiomyopathies: a machine learning approach.
    Cau R; Pisu F; Pintus A; Palmisano V; Montisci R; Suri JS; Salgado R; Saba L
    Eur Radiol; 2024 Sep; 34(9):5691-5704. PubMed ID: 38451322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Extent of Late Gadolinium Enhancement Can Predict Adverse Cardiac Outcomes in Patients with Non-Ischemic Cardiomyopathy with Reduced Left Ventricular Ejection Fraction: A Prospective Observational Study.
    Kim EK; Lee GY; Jang SY; Chang SA; Kim SM; Park SJ; Choi JO; Park SW; Choe YH; Lee SC; Oh JK
    Korean J Radiol; 2021 Mar; 22(3):324-333. PubMed ID: 32932562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary Microvascular Dysfunction as a Mechanism of Angina in Severe AS: Prospective Adenosine-Stress CMR Study.
    Ahn JH; Kim SM; Park SJ; Jeong DS; Woo MA; Jung SH; Lee SC; Park SW; Choe YH; Park PW; Oh JK
    J Am Coll Cardiol; 2016 Mar; 67(12):1412-1422. PubMed ID: 27012401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Prognosis of Patients With Coronary Microvascular Disease Using Stress Perfusion Cardiac Magnetic Resonance.
    Zhou W; Lee JCY; Leung ST; Lai A; Lee TF; Chiang JB; Cheng YW; Chan HL; Yiu KH; Goh VK; Pennell DJ; Ng MY
    JACC Cardiovasc Imaging; 2021 Mar; 14(3):602-611. PubMed ID: 33248966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy.
    Barison A; Del Torto A; Chiappino S; Aquaro GD; Todiere G; Vergaro G; Passino C; Lombardi M; Emdin M; Masci PG
    J Cardiovasc Med (Hagerstown); 2015 Oct; 16(10):681-7. PubMed ID: 26090916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.